Natural products as potential cancer therapy enhancers: A preclinical update

Abed Agbarya(Technion – Israel Institute of Technology), Jamal Mahajna(Migal - Galilee Technology Center), Nili Ruimi(Migal - Galilee Technology Center), Eran Ben‐Arye(Rappaport Family Institute for Research in the Medical Sciences), Ron Epelbaum(University of Bern)
SAGE Open Medicine
January 1, 2014
10.1177/2050312114546924
Cited by 60

Related Papers

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
|Human Reproduction|1996|266